D-0151-2020 Class II Terminated

Recalled by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center — West Columbia, SC

FDA drug recall D-0151-2020 was initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on Oct 9, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility; bags have potential to leak The recall status is terminated (terminated Dec 1, 2020). Affected quantity: 1047 bags.

Recall details

Product Type
Drugs
Report Date
Oct 30, 2019
Initiation Date
Oct 9, 2019
Termination Date
Dec 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1047 bags

Product description

del Nido Cardioplegia Solution, 1000 mL, Single-Dose Container, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-984-10

Reason for recall

Lack of Assurance of Sterility; bags have potential to leak

Distribution pattern

Nationwide.

Code information

Lots: NC9048A Exp. 10/14/2019; NC9048B Exp. 10/14/2019; NC9049A Exp. 10/16/2019; NC9049B Exp. 10/16/2019; NC9051A Exp. 10/21/2019; NC9051B Exp. 10/21/2019; NC9052A Exp. 10/22/2019; NC9052B Exp. 10/22/2019; NC9053A Exp. 10/23/2019; NC9053B Exp. 10/23/2019; NC9054A Exp. 10/28/2019; NC9054B Exp. 10/28/2019; NC9055A Exp. 10/30/2019; NC9056B Exp. 11/04/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0151-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0151-2020. Report a data issue: hello@regdatalab.com.